Cc1cc(C)c(-n2c(-c3ccc(Br)cc3)cs/c2=N\N=C2C=C(C(C)(C)C)C(=O)C(C(C)(C)C)=C2)c(C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?